Total Payments
$3,928
2024 Payments
$240.73
Companies
32
Transactions
153
Medicare Patients
14,562
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$3,256 (82.9%)
Travel$671.79 (17.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,256 | 150 | 82.9% |
| Travel and Lodging | $671.79 | 3 | 17.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $931.13 | 9 | $0 (2018) |
| Boston Scientific Corporation | $406.85 | 11 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $282.46 | 10 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $270.03 | 16 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $203.42 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $193.52 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $187.14 | 13 | $0 (2023) |
| PFIZER INC. | $170.59 | 9 | $0 (2023) |
| Medtronic Vascular, Inc. | $160.02 | 3 | $0 (2018) |
| Tactile Systems Technology Inc | $148.36 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.73 | 12 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($42.13) |
| 2023 | $530.67 | 21 | E.R. Squibb & Sons, L.L.C. ($142.59) |
| 2022 | $486.23 | 29 | Merck Sharp & Dohme LLC ($109.47) |
| 2021 | $600.38 | 32 | Novartis Pharmaceuticals Corporation ($86.65) |
| 2020 | $179.43 | 11 | PFIZER INC. ($45.66) |
| 2019 | $133.88 | 10 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($45.66) |
| 2018 | $1,056 | 13 | Abbott Laboratories ($903.95) |
| 2017 | $700.72 | 25 | BOSTON SCIENTIFIC CORPORATION ($230.05) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.02 | General |
| 09/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Not Applicable | ||||||
| 08/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Not Applicable | ||||||
| 08/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiology | ||||||
| 05/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiology | ||||||
| 04/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $29.11 | General |
| Category: Heart Failure and Hypertension | ||||||
| 03/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiology | ||||||
| 03/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/29/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/28/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.67 | General |
| Category: Not Applicable | ||||||
| 11/14/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $121.86 | General |
| Category: Cardiovascular | ||||||
| 11/06/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: NEUROLOGY | ||||||
| 10/13/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $30.88 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/04/2023 | Azurity Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiology | ||||||
| 08/23/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: DIABETES | ||||||
| 06/23/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: Cardiovascular | ||||||
| 05/31/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $23.01 | General |
| Category: Cardiovascular Device | ||||||
| 05/23/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,540 | 5,942 | $2.1M | $484,790 |
| 2022 | 19 | 3,523 | 6,009 | $2.0M | $486,136 |
| 2021 | 20 | 3,578 | 6,181 | $1.9M | $516,345 |
| 2020 | 22 | 3,921 | 6,885 | $2.3M | $592,169 |
Total Patients
14,562
Total Services
25,017
Medicare Billing
$2.1M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 515 | 1,206 | $299,088 | $110,977 | 37.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 311 | 311 | $598,675 | $109,611 | 18.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 364 | 391 | $391,000 | $58,842 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 377 | 539 | $94,325 | $35,144 | 37.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 188 | 752 | $57,152 | $33,007 | 57.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 164 | 166 | $86,320 | $23,811 | 27.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 313 | 314 | $112,680 | $23,633 | 21.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 302 | $56,776 | $18,288 | 32.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 312 | 312 | $123,240 | $15,484 | 12.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 146 | $39,128 | $13,969 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 547 | 1,141 | $91,280 | $11,915 | 13.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $18,032 | $5,639 | 31.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 55 | $19,415 | $5,607 | 28.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 35 | 35 | $12,810 | $4,317 | 33.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 17 | 18 | $9,000 | $3,445 | 38.3% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 21 | 21 | $10,584 | $3,213 | 30.4% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 51 | 54 | $12,150 | $2,620 | 21.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 41 | 47 | $13,724 | $2,569 | 18.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,731 | $1,541 | 26.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 11 | 15 | $2,520 | $829.66 | 32.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 29 | 50 | $1,750 | $327.50 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 507 | 1,105 | $274,040 | $100,410 | 36.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 224 | 224 | $431,200 | $81,965 | 19.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 392 | 439 | $439,000 | $69,552 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 410 | 721 | $126,175 | $49,411 | 39.2% |
About Dr. Mohan Kumar, M.D
Dr. Mohan Kumar, M.D is a Cardiovascular Disease healthcare provider based in Webster, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710929575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohan Kumar, M.D has received a total of $3,928 in payments from pharmaceutical and medical device companies, with $240.73 received in 2024. These payments were reported across 153 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,256).
As a Medicare-enrolled provider, Kumar has provided services to 14,562 Medicare beneficiaries, totaling 25,017 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Webster, TX
- Active Since 06/12/2006
- Last Updated 09/12/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1710929575
Products in Payments
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $702.31
- ELIQUIS (Drug) $307.33
- XARELTO (Drug) $255.74
- LifeVest (Device) $203.42
- VERQUVO (Drug) $187.14
- WATCHMAN (Device) $171.19
- CoreValve Evolut (Device) $160.02
- ENTRESTO (Drug) $155.28
- Ensite Cardiac Mapping System (Device) $153.11
- Flexitouch Plus (Device) $148.36
- CAMZYOS (Drug) $134.92
- Repatha (Biological) $103.84
- Arcalyst (Drug) $98.02
- RHYTHMIA MAPPING SYSTEM (Device) $89.71
- JARDIANCE (Drug) $88.89
- Peripheral Orbital Atherectomy System (Device) $79.93
- BRILINTA (Drug) $68.31
- WATCHMAN Access System (Device) $66.77
- NEXLETOL (Drug) $51.69
- LEQVIO (Drug) $38.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Webster
Dr. Abdelkader Almanfi, M.d, M.D
Cardiovascular Disease — Payments: $234,505
Cardiovascular Disease $234,505
Ahmad Al-Taweel, Md, MD
Cardiovascular Disease — Payments: $27,015
Cardiovascular Disease $27,015
Bahaeddin Shabaneh, Md, MD
Cardiovascular Disease — Payments: $21,788
Cardiovascular Disease $21,788
Dr. Ishwara Sharma, M.d, M.D
Cardiovascular Disease — Payments: $16,935
Cardiovascular Disease $16,935
Gerard Abreo, Md, MD
Cardiovascular Disease — Payments: $14,242
Cardiovascular Disease $14,242
Dr. Molham Aldeiri, M.d, M.D
Cardiovascular Disease — Payments: $13,972
Cardiovascular Disease $13,972